| Stereochemistry | ABSOLUTE |
| Molecular Formula | C25H25ClN2O4S |
| Molecular Weight | 484.995 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@@]1(CCN1C(=O)C2=CSC3=CC=CC=C23)C(=O)N(CCCC(O)=O)CC4=CC(Cl)=CC=C4
InChI
InChIKey=MPMKMQHJHDHPBE-RUZDIDTESA-N
InChI=1S/C25H25ClN2O4S/c1-25(11-13-28(25)23(31)20-16-33-21-9-3-2-8-19(20)21)24(32)27(12-5-10-22(29)30)15-17-6-4-7-18(26)14-17/h2-4,6-9,14,16H,5,10-13,15H2,1H3,(H,29,30)/t25-/m1/s1
| Molecular Formula | C25H25ClN2O4S |
| Molecular Weight | 484.995 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
